Tumor microenvironment (TM) refers to the cellular environment surrounding a tumor, which includes blood vessels, normal cells and molecules. The interaction between a tumor and its microenvironment results in different physiological processes providing both beneficial and adverse consequences for tumorigenesis (Quail & Joyce, 2013). Gene expression is altered in tumor cells to secrete molecules such as cytokines and growth factors and cellular components for instance exosomes to recruit stroma and vascular cells (Quail & Joyce, 2013; Mittal et al., 2014). Regardless of different tumor types and their tissue of origin there are some general hallmarks that govern tumorigenesis. Various immune effector cells can also be found in tumor microenvironment, yet their anti-tumor functions are downregulated due to tumor-derived signals such as cytokines (TL Whiteside, 2013). Hypoxia is defined as the reduction or lack of oxygen in organs, tissues or cells (Wu D. & Yotnda P., 2010). Hypoxia is a constantly evolving participant in overall tumor growth (Patel & Sant, 2016; Kim Y et al.,2009) and remains the predominant regulator of angiogenesis in the tumor microenvironment (Mittal et al., 2014). Tumor angiogenesis is normally induced by a tumor to generate its dedicated blood supply for oxygen and other nutrients by secretion of various growth factors including vascular endothelial growth factor (VEGF). VEGF promotes growth of blood vessels of a tumor and is regarded as constituent element of the tumor microenvironment (Mittal et al. 2014). In addition, acidic extracellular pH is a major feature of tumor tissue due to lactate secretion from anaerobic glycolysis and CO2 from the pentose phosphate pathway (Kato et al. 2013). Those factors that determine the nature of tumor are considered to develop targeted therapies. In our project, three of the most common characteristics of tumor microenvironment are chosen to implement one AND-Gate and control the expression of CAR.